163
Views
4
CrossRef citations to date
0
Altmetric
Research Article

In vitro activity of resorcinarene–chlorambucil conjugates for therapy in human chronic myelogenous leukemia cells

, , , , , & show all
Pages 683-688 | Received 17 Sep 2018, Accepted 03 Jan 2019, Published online: 28 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shivam Nishad, Rupa Mazumder, Swarupanjali Padhi, Malakapogu Ravindra Basu & Pratibha Pandey. (2023) Enhancement of bioavailability of therapeutics using drug conjugation approach: an in-depth review. International Journal of Polymeric Materials and Polymeric Biomaterials 0:0, pages 1-16.
Read now

Articles from other publishers (3)

Diana M. Galindres, Diego Cifuentes, Luz Elena Tinoco, Yesid Murillo-Acevedo, M. Melia Rodrigo, Ana C. F. Ribeiro & Miguel A. Esteso. (2022) A Review of the Application of Resorcinarenes and SBA-15 in Drug Delivery. Processes 10:4, pages 684.
Crossref
Luis D. Pedro-Hernández, Ulises Organista-Mateos, Luis I. Allende-Alarcón, Elena Martínez-Klimova, Teresa Ramírez-Ápan & Marcos Martínez-García. (2020) Improvement of the Anticancer Activity of Chlorambucil and Ibuprofen via Calix[4]arene Conjugates. Medicinal Chemistry 16:7, pages 984-990.
Crossref
Luis Daniel Pedro-Hernández, Carlos Hernández-Montalbán, Elena Martínez-Klimova, Teresa Ramírez-Ápan & Marcos Martínez-García. (2020) Synthesis and anticancer activity of open-resorcinarene conjugates. Bioorganic & Medicinal Chemistry Letters 30:14, pages 127275.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.